Ultragenyx Pharmaceutical Cash from Financing (TTM) Insights

Ultragenyx Pharmaceutical Inc (RARE)

42.39 -0.96 (-2.21%) USD | NASDAQ | Apr 19, 16:00

42.39 0.00 (0.00%) After-Hours: 20:00

Cash from Financing (TTM) Chart

Historical Cash from Financing (TTM) Data

View and export this data back to 2013. Upgrade now.

Date	Value
December 31, 2023	388.14M
September 30, 2023	59.41M
June 30, 2023	526.06M
March 31, 2023	498.87M
December 31, 2022	501.21M
September 30, 2022	585.05M
June 30, 2022	100.72M
March 31, 2022	107.52M
December 31, 2021	118.55M
September 30, 2021	522.54M
June 30, 2021	534.12M
March 31, 2021	557.31M
December 31, 2020	600.27M
September 30, 2020	426.00M
June 30, 2020	407.77M
March 31, 2020	381.30M
December 31, 2019	679.31M
September 30, 2019	376.10M
June 30, 2019	400.22M
March 31, 2019	404.05M
December 31, 2018	336.85M

Date	Value
September 30, 2018	389.05M
June 30, 2018	365.36M
March 31, 2018	353.72M
December 31, 2017	136.27M
September 30, 2017	146.77M
June 30, 2017	208.88M
March 31, 2017	207.33M
December 31, 2016	138.68M
September 30, 2016	64.62M
June 30, 2016	289.83M
March 31, 2016	292.45M
December 31, 2015	467.57M
September 30, 2015	467.10M
June 30, 2015	238.96M
March 31, 2015	236.37M
December 31, 2014	184.97M
September 30, 2014	184.60M
June 30, 2014	124.16M
March 31, 2014	124.21M
December 31, 2013	0.171M

Cash From Financing Definition

Cash flow from financing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall financing activities of the company. A few examples of financing activities include common stock issuance, total dividends paid, and net debt issuance.

Read full definition.

Cash from Financing (TTM) Range, Past 5 Years

59.41M

Minimum

Sep 2023

679.31M

Maximum

Dec 2019

408.97M

Average

426.00M

Median

Sep 2020

Cash from Financing (TTM) Benchmarks